EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?
Drug resistance is a major impediment to patient survival and remains the primary cause of unsuccessful cancer therapy. Drug resistance occurs in many tumors and is frequently induced by chemotherapy which triggers a defensive response both in cancerous and cancer-associated cells that constitute th...
Main Authors: | Mauro Di Vito Nolfi, Davide Vecchiotti, Irene Flati, Daniela Verzella, Monica Di Padova, Edoardo Alesse, Daria Capece, Francesca Zazzeroni |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.933922/full |
Similar Items
-
NF-κB: A Druggable Target in Acute Myeloid Leukemia
by: Barbara Di Francesco, et al.
Published: (2022-07-01) -
Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer
by: Davide Vecchiotti, et al.
Published: (2022-07-01) -
The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable Target
by: Daniela Verzella, et al.
Published: (2022-09-01) -
Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression
by: Irene Flati, et al.
Published: (2023-10-01) -
NF-κB: Governing Macrophages in Cancer
by: Jessica Cornice, et al.
Published: (2024-01-01)